Lisdexamfetamine dimesylate had no apparent effects on embryo-fetal morphological development or survival when administered orally to pregnant rats and rabbits throughout the period of organogenesis at doses of up to 40 and 120 mg/kg/day, respectively. May enhance the activity of tricyclic or sympathomimetic agents causing striking and sustained increases rein https://georgeg283ths3.webbuzzfeed.com/profile